Skip to main content
CVD events, mortality may be curbed with ezetimibe-statin combo

Adults with and without established cardiovascular disease who received ezetimibe with statin therapy had a modestly lower risk of major adverse CV events and all-cause mortality, compared with those who took statins alone, researchers reported in the Cochrane Database of Systematic Reviews. The findings were based on a systematic review and meta-analysis of 26 studies with 23,499 total individuals.

Full Story: